E. KEVIN HRUSOVSKY - 27 Jul 2021 Form 3 Insider Report for DA32 Life Science Tech Acquisition Corp.

Role
Director
Signature
/s/ Henrikki Harsu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Jul 2021
Net transactions value
$0
Form type
3
Filing time
27 Jul 2021, 20:10:55 UTC
Previous filing
14 Jul 2021
Next filing
30 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DALS Class B Common Stock 27 Jul 2021 Class A Common Stock 30,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date.

Remarks:

See Exhibit 24.1 - Power of Attorney.